Sugi Predict

Sugi Predict / Compounds / SCHEMBL146502

SCHEMBL146502

SCHEMBL146502

C1=CCC(c2cccc3cc4ccc5cc6ccccc6cc5c4cc23)=C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.40
▸ HSD17B10 Q99714 4/20 0.40
▸ HPGD P15428 3/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ HIF1A Q16665 3/20 0.37
▸ CYP1B1 Q16678 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.33
▸ GAA P10253 2/20 0.33
▸ TSHR P16473 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ CASP1 P29466 2/20 0.32
▸ ERBB2 P04626 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ AHR P35869 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ HTR1A P08908 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17025979 0.98 ALDH1A1 (0.39) ALDH1A1HSD17B10HPGDCYP1A2HIF1A
SCHEMBL28469696 0.98 ALDH1A1 (0.39) ALDH1A1HSD17B10HPGDCYP1A2HIF1A
SCHEMBL27854717 0.91 ALDH1A1 (0.34) ALDH1A1HSD17B10HPGDCYP1A2HIF1A
Diethylaniline SCHEMBL28184642 0.86 CNR2 (0.34) ALDH1A1HSD17B10HPGDCYP1A2KDM4E
SCHEMBL27612072 0.86 ALDH1A1 (0.38) ALDH1A1HSD17B10HPGDCYP1A2HIF1A
SCHEMBL5556074 0.85 ALDH1A1 (0.35) ALDH1A1HSD17B10HPGDCYP1A2HIF1A
SCHEMBL27627835 0.84 ALDH1A1 (0.31) ALDH1A1HSD17B10HPGDCYP1A2MAPK1
SCHEMBL5696379 0.80 SLC6A3 (0.41) ALDH1A1HSD17B10HPGDCYP1A2KDM4E
SCHEMBL9268395 0.79 HPRT1 (0.48) ALDH1A1HSD17B10HPGDCYP1A2HIF1A
SCHEMBL6242909 0.78 SLC6A3 (0.40) ALDH1A1HSD17B10CYP1A2KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 756 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085235-A1 HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES UDC IRELAND LTD (IE) 2026-03-26 — — US claimed
EP-4600326-A2 HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES UDC Ireland Limited (IE) 2025-08-13 — — EP claimed
CN-114225968-A Ethylene trimerization catalyst composition 中化泉州石化有限公司 2022-03-25 — — CN claimed
CN-111747994-A Diamino dicyclopentadienyl molybdenum complex and its preparation method and application 苏州欣溪源新材料科技有限公司 2020-10-09 — — CN claimed
EP-3309236-A1 COMPOSITIONS COMPRISING QUANTUM DOTS Merck Patent GmbH (DE) 2018-04-18 — — EP claimed
US-9923152-B2 Organic ionic functional materials MERCK PATENT GMBH (DE) 2018-03-20 — — US claimed
US-9193902-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2015-11-24 — — US claimed
US-5922396-A Electron transporting and light emitting layers based on organic free radicals THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 1999-07-13 — — US claimed
US-5747183-A Organic electroluminescent light emitting material and device using same MOTOROLA, INC. (US) 1998-05-05 — — US claimed
WO-2026104430-A1 USE OF SILICON COMPOUNDS IN AN ELECTRONIC DEVICE MERCK PATENT GMBH (DE) 2026-05-21 — — WO disclosed
US-12614943-B2 Electrical operating means having an insulation system, and method for producing the insulation system SIEMENS AKTIENGESELLSCHAFT (DE) 2026-04-28 — — US disclosed
EP-4079742-B1 METAL COMPLEXES UDC IRELAND LTD (IE) 2026-04-01 — — EP disclosed
US-20260085235-A1 HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES UDC IRELAND LTD (IE) 2026-03-26 — — US disclosed
US-12521919-B2 Anisotropic film and method for manufacturing anisotropic film SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-01-13 — — US disclosed
US-5223468-A Process and catalyst for producing syndiotactic polymers FINA TECHNOLOGY, INC. (US) 1993-06-29 — — US disclosed
EP-0532798-A1 An electroluminescent element ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1993-03-24 — — EP disclosed
US-5162278-A Non-bridged syndiospecific metallocene catalysts and polymerization process FINA TECHNOLOGY, INC. (US) 1992-11-10 — — US disclosed
EP-0423100-A2 Process and catalyst for producing syndiotactic polymers FINA TECHNOLOGY, INC. (US) 1991-04-17 — — EP disclosed
US-4812587-A Process for selective hydrogenation of C--C double bonds in the presence of reducible, nitrogen-containing groups and new ruthenium complex compounds BAYER AKTIENGESELLSCHAFT (DE) 1989-03-14 — — US disclosed
US-4673757-A Process for selective hydrogenation of C-C double bonds in the presence of reducible, nitrogen-containing groups and new ruthenium complex compounds BAYER AKTIENGESELLSCHAFT (DE) 1987-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085235-A1 HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES CCND2, CCND1, CCNE2 ALDH1A1 2001/4885HSD17B10 3311/4885HPGD 3869/4885
US-12614943-B2 Electrical operating means having an insulation system, and method for producing the insulation system SCO2, RAE1, FTO ALDH1A1 618/4885HSD17B10 1658/4885HPGD 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.